Skip to main content

People in the News: Kevin Buchi

Premium

Benitec Biopharma has appointed Kevin Buchi to its board of directors.

Buchi previously served as CEO of Cephalon prior to its acquisition by Teva Pharmaceutical in 2011. He currently sits on the boards of Stemline Therapeutics, Forward Pharma, and Alexza Pharamceuticals.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.